• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度饮酒习惯是非酒精性脂肪性肝病伴进展性肝纤维化患者发生肝癌的一个危险因素。

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.

机构信息

Department of Internal Medicine, Division of Gastroenterology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

Department of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan.

出版信息

World J Gastroenterol. 2018 Apr 7;24(13):1440-1450. doi: 10.3748/wjg.v24.i13.1440.

DOI:10.3748/wjg.v24.i13.1440
PMID:29632425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5889824/
Abstract

AIM

The impact of mild drinking habit (less than 20 g/d of ethanol) on the clinical course of non-alcoholic fatty liver disease (NAFLD) has not been determined. We examined the influence of a mild drinking habit on liver carcinogenesis from NAFLD.

METHODS

A total of 301 patients who had been diagnosed as having NAFLD by liver biopsy between 2003 and 2016 [median age: 56 years, 45% male, 56% with non-alcoholic steatohepatitis, 26% with advanced fibrosis (F3-4)] were divided into the mild drinking group with ethanol consumption of less than 20 g/d (mild drinking group, = 93) and the non-drinking group ( = 208). Clinicopathological features at the time of liver biopsy and factors related to hepatocellular carcinoma (HCC) occurrence were compared between the groups.

RESULTS

We observed significant differences in male prevalence ( = 0.01), platelet count ( = 0.04), and gamma-glutamyl transpeptidase ( = 0.02) between the test groups. Over 6 years of observation, the HCC appearance rate was significantly higher in the mild drinking group (6.5% 1.4%, = 0.02). Multivariate survival analysis using Cox's regression model revealed that hepatic advanced fibrosis (F3-4) ( < 0.01, risk ratio: 11.60), diabetes mellitus ( < 0.01, risk ratio: 89.50), and serum triglyceride ( = 0.04, risk ratio: 0.98) were factors significantly related to HCC in all NAFLD patients, while the effect of a drinking habit was marginal ( = 0.07, risk ratio: 4.43). In patients with advanced fibrosis (F3-4), however, a drinking habit ( = 0.04, risk ratio: 4.83), alpha-fetoprotein ( = 0.01, risk ratio: 1.23), and diabetes mellitus ( = 0.03, risk ratio: 12.00) were identified as significant contributors to HCC occurrence.

CONCLUSION

A mild drinking habit appears to be a risk factor for hepatocarcinogenesis in NAFLD patients, especially those with advanced fibrosis.

摘要

目的

轻度饮酒习惯(每天乙醇摄入量<20g)对非酒精性脂肪性肝病(NAFLD)临床病程的影响尚未确定。本研究旨在探讨轻度饮酒习惯对由 NAFLD 导致的肝癌发生的影响。

方法

2003 年至 2016 年间,通过肝活检诊断为 NAFLD 的 301 例患者[中位年龄:56 岁,45%为男性,56%为非酒精性脂肪性肝炎,26%为晚期纤维化(F3-4)],将其分为乙醇摄入量<20g/d 的轻度饮酒组(轻度饮酒组,n=93)和非饮酒组(n=208)。比较两组患者肝活检时的临床病理特征及与肝细胞癌(HCC)发生相关的因素。

结果

两组间男性患病率(P=0.01)、血小板计数(P=0.04)和γ-谷氨酰转肽酶(P=0.02)存在显著差异。在 6 年的观察期间,轻度饮酒组 HCC 发生率明显更高(6.5% vs. 1.4%,P=0.02)。多因素生存分析采用 Cox 回归模型显示,肝纤维化晚期(F3-4)(P<0.01,风险比:11.60)、糖尿病(P<0.01,风险比:89.50)和血清三酰甘油(P=0.04,风险比:0.98)是所有 NAFLD 患者 HCC 的显著相关因素,而饮酒习惯的影响具有边缘意义(P=0.07,风险比:4.43)。然而,在纤维化晚期(F3-4)的患者中,饮酒习惯(P=0.04,风险比:4.83)、甲胎蛋白(P=0.01,风险比:1.23)和糖尿病(P=0.03,风险比:12.00)是 HCC 发生的显著因素。

结论

轻度饮酒习惯似乎是 NAFLD 患者发生肝癌的危险因素,尤其是纤维化晚期的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/5889824/cf221ad3867c/WJG-24-1440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/5889824/1dee1b2631ea/WJG-24-1440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/5889824/1d5663e75f62/WJG-24-1440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/5889824/cf221ad3867c/WJG-24-1440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/5889824/1dee1b2631ea/WJG-24-1440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/5889824/1d5663e75f62/WJG-24-1440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/5889824/cf221ad3867c/WJG-24-1440-g003.jpg

相似文献

1
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.轻度饮酒习惯是非酒精性脂肪性肝病伴进展性肝纤维化患者发生肝癌的一个危险因素。
World J Gastroenterol. 2018 Apr 7;24(13):1440-1450. doi: 10.3748/wjg.v24.i13.1440.
2
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.纤维化严重程度是晚期非酒精性脂肪性肝病患者死因特异性死亡率的决定因素:一项多国队列研究。
Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5.
3
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.非酒精性脂肪性肝病患者中无晚期纤维化的肝细胞癌的临床特征。
J Gastroenterol Hepatol. 2019 Sep;34(9):1626-1632. doi: 10.1111/jgh.14608. Epub 2019 Mar 6.
4
Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.日本非酒精性脂肪性肝病中的肝癌发生。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239.
5
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
6
Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population.在日本人群中,非酒精性脂肪性肝病的长期结局以及死亡和肝细胞癌的风险因素。
J Gastroenterol Hepatol. 2020 Sep;35(9):1579-1589. doi: 10.1111/jgh.14989. Epub 2020 Feb 5.
7
The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.非酒精性脂肪性肝病无肝硬化患者肝细胞癌的特征和危险因素。
J Gastroenterol Hepatol. 2020 May;35(5):862-869. doi: 10.1111/jgh.14867. Epub 2019 Dec 3.
8
Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.无创性纤维化标志物在预测日本活检证实的非酒精性脂肪性肝病患者预后中的作用和局限性。
J Gastroenterol Hepatol. 2019 Jan;34(1):207-214. doi: 10.1111/jgh.14448. Epub 2018 Sep 18.
9
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.非肝硬化非酒精性脂肪性肝病(NAFLD)患者肝细胞癌(HCC)的特征
Hepatol Int. 2016 Jul;10(4):632-9. doi: 10.1007/s12072-015-9679-0. Epub 2015 Nov 11.
10
Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.日本非酒精性脂肪性肝病患者发生肝细胞癌的大规模长期随访研究。
Am J Gastroenterol. 2012 Feb;107(2):253-61. doi: 10.1038/ajg.2011.327. Epub 2011 Oct 18.

引用本文的文献

1
Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies.肝细胞癌的当代流行病学:了解风险因素和监测策略。
J Can Assoc Gastroenterol. 2024 Aug 9;7(5):331-345. doi: 10.1093/jcag/gwae025. eCollection 2024 Oct.
2
Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review.代谢功能障碍相关脂肪性肝炎相关肝细胞癌的发病机制与管理:一篇叙述性综述
Ewha Med J. 2024 Oct;47(4):e65. doi: 10.12771/emj.2024.e65. Epub 2024 Oct 31.
3
The importance of patient engagement in the multimodal treatment of MASLD.

本文引用的文献

1
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame.酒精与肝细胞癌:火上浇油
Cancers (Basel). 2017 Sep 25;9(10):130. doi: 10.3390/cancers9100130.
2
Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.生长停滞和 DNA 损伤诱导蛋白 45α 可预防蛋氨酸和胆碱缺乏饮食诱导的非酒精性脂肪性肝炎。
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3170-3182. doi: 10.1016/j.bbadis.2017.08.017. Epub 2017 Aug 24.
3
Association between lower air pressure and the onset of ischemic colitis: a case-control study.
患者参与非酒精性脂肪性肝炎多模式治疗的重要性。
Commun Med (Lond). 2025 May 1;5(1):148. doi: 10.1038/s43856-025-00871-1.
4
Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors.酒精在脂肪性肝病中的作用:对伴有心脏代谢危险因素患者的影响。
Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08912-4.
5
MetALD: Clinical aspects, pathophysiology and treatment.线粒体酒精性肝病:临床特征、病理生理学及治疗
JHEP Rep. 2024 Nov 2;7(2):101250. doi: 10.1016/j.jhepr.2024.101250. eCollection 2025 Feb.
6
Hormone replacement therapy for steatotic liver management after surgical menopause.手术绝经后脂肪性肝病管理的激素替代疗法。
Clin J Gastroenterol. 2025 Apr;18(2):352-356. doi: 10.1007/s12328-024-02090-y. Epub 2025 Jan 6.
7
Circulating thrombospondin 2 as a predictor of hepatocellular carcinoma in hepatitis B patients undergoing nucleos(t)ide analog therapy.循环型血小板反应蛋白 2 可预测核苷(酸)类似物治疗的乙型肝炎患者发生肝细胞癌。
Sci Rep. 2024 Oct 26;14(1):25584. doi: 10.1038/s41598-024-76532-5.
8
Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy.血小板反应蛋白2作为丙型肝炎患者肝癌的预测生物标志物:直接抗病毒药物治疗后的纵向研究
J Viral Hepat. 2025 Apr;32(4):e14025. doi: 10.1111/jvh.14025. Epub 2024 Oct 15.
9
Hepatic changes following a high-fat diet: effects of and gold nanoparticles phytoreduced with on oxidative stress, inflammation, and histological damage.高脂饮食后的肝脏变化:用[具体植物名称]植物还原的[具体物质]和金纳米颗粒对氧化应激、炎症及组织学损伤的影响
Med Pharm Rep. 2024 Jul;97(3):318-329. doi: 10.15386/mpr-2775. Epub 2024 Jul 30.
10
Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B.慢性乙型肝炎合并肝细胞癌的临床表现及相关因素比较
Int J Gen Med. 2024 Jun 25;17:2877-2886. doi: 10.2147/IJGM.S464083. eCollection 2024.
低气压与缺血性结肠炎发病之间的关联:一项病例对照研究。
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1071-1078. doi: 10.1097/MEG.0000000000000913.
4
Targeting nuclear receptors for the treatment of fatty liver disease.针对核受体治疗脂肪肝。
Pharmacol Ther. 2017 Nov;179:142-157. doi: 10.1016/j.pharmthera.2017.05.011. Epub 2017 May 23.
5
Association between endotoxemia and histological features of nonalcoholic fatty liver disease.内毒素血症与非酒精性脂肪性肝病组织学特征之间的关联
World J Gastroenterol. 2017 Jan 28;23(4):712-722. doi: 10.3748/wjg.v23.i4.712.
6
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.非酒精性脂肪性肝病中适度饮酒是好是坏?一项批判性综述。
Hepatology. 2017 Jun;65(6):2090-2099. doi: 10.1002/hep.29055. Epub 2017 Apr 28.
7
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.无既往乙型肝炎病毒感染的非B非C型肝细胞癌的临床病理特征
Hepatol Res. 2017 Apr;47(5):405-418. doi: 10.1111/hepr.12762. Epub 2016 Jul 24.
8
Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.受控衰减参数与非酒精性脂肪性肝病伴无至轻度肥胖和肝纤维化患者的实际肝脂肪含量相关。
Hepatol Res. 2016 Sep;46(10):1019-27. doi: 10.1111/hepr.12649. Epub 2016 Mar 15.
9
Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.酒精性肝病促进的早期肝细胞癌成年小鼠模型
World J Gastroenterol. 2016 Apr 28;22(16):4091-108. doi: 10.3748/wjg.v22.i16.4091.
10
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants.1975年至2014年200个国家成人身体质量指数的趋势:对1698项基于人群测量研究的汇总分析,涉及1920万参与者。
Lancet. 2016 Apr 2;387(10026):1377-1396. doi: 10.1016/S0140-6736(16)30054-X.